| THEA Pharma S.A. - Virgan 1.5 mg/g, gel ophtalmique | | 67710 | | 01 | | Virgan 1.5 mg/g | | gel ophtalmique | | S01AD09 | | Ganciclovir | | 04.12.2020 | | |
| | Composition | | ganciclovirum 7.5 mg, carbomerum 974P, sorbitolum, natrii hydroxidum ad pH, benzalkonii chloridum 0.375 mg, aqua ad iniectabile, ad gelatum pro 5 g. | | Packungsbestandteile | | Ophtalmic gel | | | | | Active Agent | Dose |
|---|
| Ganciclovir | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Ganciclovir | 1.5 mg |
| | | | Inactive agents | Dose |
|---|
| Ad Gelatum | 100 g | | Aqua Purificata | | | Benzalkonium Chloride | 7.5 mg | | Carbomerum 974P | | | Sodium Hydroxide | | | Sorbitol | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 5 g | 10.77 | 28.15 | A | SL | No |
|
|